Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for … – MarketWatch
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for … – MarketWatch
Titan Pharmaceuticals Announces Agreement in Principle on Path Forward for …
MarketWatch The proposed clinical study will be a randomized, double blind and double dummy design that will provide information for a non-inferiority comparison of a six-month treatment with a dose of four Probuphine implants to treatment with 8mg or less of an … |
Methadone Maintenance – Google News
More Methadone Maintenance Information…